Eli Lilly Just Made a $2.8 Billion Bet That Goes Beyond GLP-1 Drugs
5 Articles
5 Articles
Eli Lilly, a pharmaceutical owner of Mounjaro, today announced positive results of two Phase 3 clinical trials (the last step before approval) of retatrutide, her new medicine focused on weight reduction and type 2 diabetes control.
AtaiBeckley Shares at $7.17 as Lilly Agreement Sets CVR at 42 Cents
NEW YORK, July 28, 2026, 1:05 p.m. EDT — Nasdaq begins trading (MarketWatch) Shares of AtaiBeckley Inc. (NASDAQ:ATAI) remained flat at $7.17 as of 1 p.m. on Tuesday. This price stood 42 cents higher than Eli Lilly and Co.'s (NYSE:LLY) $6.75 cash offer at close. (MarketWatch) Without discounting, the gap values the CVR at 42…
Eli Lilly $6.5bn Manufacturing Plant in Generation Park in Limbo with Operations Set for 2030
The construction of Eli Lilly’s $6.5bn manufacturing plant in Generation Park is in limbo as the project still aims for 2030 operations. Local news channels in Houston note that construction on several projects are either underway or set to begin in August. The firm is associated with pharmaceutical giant Eli Lilly and Company’s planned 236-acre […] The post Eli Lilly $6.5bn Manufacturing Plant in Generation Park in Limbo with Operations Set for…
ISCO Industries celebrates new $12.75M Louisville manufacturing plant - The Lexington Times
LOUISVILLE, Ky. — Global piping products supplier ISCO Industries officially opened its new $12.75 million manufacturing facility on Johnsontown Road, marking a significant expansion of the company’s Louisville footprint and doubling its current operations in the region. The project is expected to create 50 full-time jobs while enhancing the company’s fabrication capabilities. According to an announcement from Governor Andy Beshear’s office, the…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
